OptimizeRx Corp — Director's Dealing 2019

Mar 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2019-03-27

Reporting Person: BAKER DOUGLAS P (CHIEF FINANCIAL OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-27	Common Stock	A	16667	—	Acquired	48551	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-27	Contingent Stock Grant	$	C	16667	Disposed		Common Stock (16667)	Direct

Footnotes

F1: The reporting person received a contingent stock grant subject to achievement of the Issuer's 2018 year-end revenue performance goals that were achieved for the year.

F2: Not applicable